BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 12, 2018
View Archived Issues
Novartis enrolling participants in phase II trial of NIR-178
Read More
BI-2545 shows promise for the unmet medical need in IPF treatment
Read More
UCB studies bimekizumab in phase III for moderate to severe chronic plaque psoriasis
Read More
Chiesi initiates phase I/II study of CHF-6366 for asthma and COPD
Read More
Libella Gene Therapeutics begins clinical trial of telomerase gene therapy for Alzheimer's
Read More
Immunomedics enters agreement to test sacituzumab govitecan in prostate cancer
Read More
CEO describes development activity at Alkermes
Read More
Anti-MERS human antibody derived from transchromosomic cattle safe in phase I trial
Read More
Forty Seven enters two agreements for studies of Hu5F9-G4
Read More
FDA advisory committee does not recommend approval of Linhaliq
Read More
FDA advisory committee votes against testosterone replacement therapy Tlando
Read More
Novel HSPG-mimicking nanoparticles show broad-spectrum virucidal activity
Read More
HedgePath to receive new investment from Mayne Pharma
Read More
Ligand and Glenmark enter OmniAb license agreement
Read More
Aviragen reiterates support for pending merger with Vaxart
Read More
Astellas submits application for additional indication for ipragliflozin in Japan
Read More
Nippon Chemiphar's NC-2800 selected for AMED progrram
Read More
Aequus and CannaRoyalty to jointly develop cannabis-based therapies
Read More
FDA approves expanded use of Fluarix Quadrivalent from 6 months of age
Read More
FronThera US Pharmaceuticals presents novel hemoglobin modifier compounds
Read More
Syndax Pharmaceuticals, Genentech to test entinostat with atezolizumab
Read More
Bristol-Myers Squibb patents lysophosphatidic acid receptor antagonists
Read More
New nuclear receptor ROR-gamma antagonists discovered at Fudan University
Read More
Medchem Partners discovers novel nitric oxide donors
Read More
Novel HIV maturation inhibitors identified at ViiV Healthcare
Read More
Pharmazz eyes studies of PMZ-1620 in ALS
Read More
European Commission approves Ocrevus for relapsing MS and primary progressive MS
Read More